Cargando…
Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
For several decades, multipotent mesenchymal stromal cells (MSCs) have been extensively studied for their therapeutic potential across a wide range of diseases. In the preclinical setting, MSCs demonstrate consistent ability to promote tissue healing, down-regulate excessive inflammation and improve...
Autores principales: | Caplan, Henry, Olson, Scott D., Kumar, Akshita, George, Mitchell, Prabhakara, Karthik S., Wenzel, Pamela, Bedi, Supinder, Toledano-Furman, Naama E., Triolo, Fabio, Kamhieh-Milz, Julian, Moll, Guido, Cox, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685059/ https://www.ncbi.nlm.nih.gov/pubmed/31417542 http://dx.doi.org/10.3389/fimmu.2019.01645 |
Ejemplares similares
-
Time dependent analysis of rat microglial surface markers in traumatic brain injury reveals dynamics of distinct cell subpopulations
por: Gottlieb, Assaf, et al.
Publicado: (2022) -
High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis
por: Toledano Furman, Naama, et al.
Publicado: (2020) -
Human cord blood‐derived regulatory T‐cell therapy modulates the central and peripheral immune response after traumatic brain injury
por: Caplan, Henry W., et al.
Publicado: (2020) -
Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury
por: Ruppert, Katherine A., et al.
Publicado: (2018) -
Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model
por: Caplan, Henry W., et al.
Publicado: (2021)